Sign in

CIK 0001104506

  • Large accelerated filer
Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
EIN
541972729
Phone
+1 908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,100,000
in 1 filing

Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brennan David R −$3.1M Director sold 39% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-05-15 LEE LEO Director Grant or award +5,058 129,677
2025-05-14 Smith Michael Alexander Chief Legal Officer Sale −409 $65.61 $27K 91,794
2025-05-14 Schaeffer Orlov S Nicole Chief People Strategy Officer Sale −1,236 $65.61 $81K 114,643
2025-05-14 Lewis William Chair and CEO Sale −3,771 $65.61 $247K 312,973
2025-05-14 Flammer Martina M.D. Chief Medical Officer Sale −1,744 $65.61 $114K 90,013
2025-05-14 Bonstein Sara Chief Financial Officer Sale −1,634 $65.61 $107K 108,359
2025-05-14 Adsett Roger Chief Operating Officer Sale −1,925 $65.61 $126K 136,675
2025-05-14 SHAROKY MELVIN MD Director Gift −576 296,158
2025-05-14 SHAROKY MELVIN MD Director Gift +576 576
2025-05-13 Smith Michael Alexander Chief Legal Officer Sale −4,407 $67.81 $299K 92,203
2025-05-13 Schaeffer Orlov S Nicole Chief People Strategy Officer Sale −4,999 $67.81 $339K 115,879
2025-05-13 Lewis William Chair and CEO Sale −9,743 $66.40 $647K 324,443
2025-05-13 Lewis William Chair and CEO Sale −7,699 $67.70 $521K 316,744
2025-05-13 Flammer Martina M.D. Chief Medical Officer Sale −8,408 $67.81 $570K 91,757
2025-05-13 Bonstein Sara Chief Financial Officer Sale −8,870 $67.81 $601K 109,993
2025-05-13 Adsett Roger Chief Operating Officer Sale −7,482 $67.81 $507K 138,600
2025-05-01 Lewis William Chair and CEO Exercise or conversion 10b5-1 +6,830 $10.85 $74K 240,754
2025-05-01 Lewis William Chair and CEO Sale 10b5-1 −2,629 $72.24 $190K 238,125
2025-05-01 Lewis William Chair and CEO Sale 10b5-1 −4,201 $72.78 $306K 233,924
2025-05-01 Lewis William Chair and CEO Exercise or conversion · Stock Option (right to buy) 10b5-1 −6,830 170,820

Page 26 of 42 · 826 trades